There have been 50 recent insider transactions recorded for Verona Pharma plc (VRNA), including 15 buys and 34 sells. Total insider buying was valued at $431.64K and total insider selling at $39.14M.
Notable insiders with recent activity include Fisher Andrew, Hahn Mark W, Zaccardelli David. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — VRNA
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-06-16 |
Fisher Andrew |
General Counsel |
Informative Sell |
80,000 |
$11.53 |
$922K |
359,999 |
| 2025-06-11 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
400,000 |
$11.40 |
$4.56M |
12,278,992 |
| 2025-06-11 |
Zaccardelli David |
President and CEO |
Informative Sell |
400,000 |
$11.40 |
$4.56M |
13,190,168 |
| 2025-05-29 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
204,864 |
$9.33 |
$1.91M |
12,678,992 |
| 2025-05-29 |
Zaccardelli David |
President and CEO |
Informative Sell |
208,696 |
$9.33 |
$1.95M |
13,590,168 |
| 2025-05-28 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
162,704 |
$9.30 |
$1.51M |
12,883,856 |
| 2025-05-28 |
Zaccardelli David |
President and CEO |
Informative Sell |
157,704 |
$9.30 |
$1.47M |
13,798,864 |
| 2025-05-27 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
32,432 |
$9.53 |
$308.98K |
13,046,560 |
| 2025-05-27 |
Zaccardelli David |
President and CEO |
Informative Sell |
33,600 |
$9.53 |
$320.18K |
13,956,568 |
| 2025-05-20 |
Sinha Vikas |
Director |
Option Exercise (Sell) |
160,000 |
$0.50 |
$80.61K |
384 |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
Informative Sell |
80,000 |
$8.57 |
$685.6K |
359,999 |
| 2025-05-15 |
Fisher Andrew |
General Counsel |
Option Exercise |
80,000 |
$2.01 |
$160.9K |
439,999 |
| 2025-05-14 |
Ackermann Christina |
Director |
Informative Sell |
40,000 |
$8.44 |
$337.6K |
41,880 |
| 2025-05-06 |
Rickard Kathleen A. |
Chief Medical Officer |
Informative Sell |
114,984 |
$8.82 |
$1.01M |
2,546,472 |
| 2025-05-02 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
400,000 |
$9.09 |
$3.64M |
13,078,992 |
| 2025-05-02 |
Zaccardelli David |
President and CEO |
Informative Sell |
400,000 |
$9.09 |
$3.64M |
13,990,168 |
| 2025-05-01 |
Ebsworth David R |
Director |
Option Exercise |
140,000 |
$1.93 |
$270.73K |
- |
| 2025-05-01 |
Hahn Mark W |
Chief Financial Officer |
Option Exercise (Sell) |
200,000 |
- |
- |
1,000,000 |
| 2025-05-01 |
Zaccardelli David |
President and CEO |
Option Exercise (Sell) |
200,000 |
- |
- |
1,000,000 |
| 2025-05-01 |
Rickard Kathleen A. |
Chief Medical Officer |
Option Exercise (Sell) |
50,000 |
- |
- |
250,000 |
| 2025-04-29 |
Sinha Vikas |
Director |
Informative Sell |
4,952 |
$8.92 |
$44.18K |
74,440 |
| 2025-04-29 |
Hahn Mark W |
Chief Financial Officer |
Option Exercise (Sell) |
229,512 |
- |
- |
445,488 |
| 2025-04-29 |
Zaccardelli David |
President and CEO |
Option Exercise (Sell) |
229,512 |
- |
- |
445,488 |
| 2025-04-29 |
Rickard Kathleen A. |
Chief Medical Officer |
Option Exercise (Sell) |
86,064 |
- |
- |
167,056 |
| 2025-04-29 |
Fisher Andrew |
General Counsel |
Option Exercise (Sell) |
86,064 |
- |
- |
167,056 |
| 2025-04-29 |
Sinha Vikas |
Director |
Option Exercise (Sell) |
120,384 |
$1.70 |
$204.65K |
- |
| 2025-04-25 |
Ebsworth David R |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Shah Mahendra |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Sinha Vikas |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Edwards Martin |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Ackermann Christina |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Ullman Anders |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Cunningham Kenneth |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Deschamps Lisa |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Brady James Aloysius |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-04-25 |
Austwick Michael |
Director |
RSU Award |
96,000 |
- |
- |
96,000 |
| 2025-03-19 |
Fisher Andrew |
General Counsel |
Gift (Received) |
1 |
- |
- |
300,001 |
| 2025-03-12 |
Rickard Kathleen A. |
Chief Medical Officer |
Informative Sell |
79,264 |
$8.35 |
$661.94K |
2,608,976 |
| 2025-02-26 |
Ebsworth David R |
Director |
Option Exercise (Sell) |
96,000 |
$2.67 |
$256.32K |
- |
| 2025-02-03 |
Hahn Mark W |
Chief Financial Officer |
Tax Withholding of RSU |
166,888 |
$7.16 |
$1.2M |
13,326,848 |
| 2025-02-03 |
Zaccardelli David |
President and CEO |
Tax Withholding of RSU |
166,728 |
$7.16 |
$1.19M |
14,238,024 |
| 2025-02-03 |
Rickard Kathleen A. |
Chief Medical Officer |
Tax Withholding of RSU |
33,240 |
$7.16 |
$238.08K |
2,688,240 |
| 2025-02-01 |
Hahn Mark W |
Chief Financial Officer |
RSU Award |
200,000 |
- |
- |
13,493,736 |
| 2025-02-01 |
Zaccardelli David |
President and CEO |
RSU Award |
200,000 |
- |
- |
14,404,752 |
| 2025-02-01 |
Rickard Kathleen A. |
Chief Medical Officer |
RSU Award |
50,000 |
- |
- |
2,721,480 |
| 2024-12-06 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
183,728 |
$5.01 |
$920.31K |
13,293,736 |
| 2024-12-06 |
Zaccardelli David |
President and CEO |
Informative Sell |
162,800 |
$5.01 |
$815.4K |
14,204,752 |
| 2024-12-05 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
640,048 |
$5.01 |
$3.2M |
13,477,464 |
| 2024-12-05 |
Zaccardelli David |
President and CEO |
Informative Sell |
640,264 |
$5.01 |
$3.21M |
14,367,552 |
| 2024-12-04 |
Hahn Mark W |
Chief Financial Officer |
Informative Sell |
58,184 |
$5.00 |
$291K |
14,117,512 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
